Newsletter
Every new paper in this field, in your inbox.
Neoadjuvant chemotherapy does not improve disease-free survival compared to upfront surgery for locally advanced colon cancer, but shows benefits in feasibility and reduced need for adjuvant therapy.
taTME shows promising long-term outcomes for low rectal cancer patients, crucial for surgical practice.
Surgeons can now preoperatively assess wound complication risk using a newly validated scoring model for internal hemipelvectomy.
High adherence to enhanced recovery program components can significantly cut costs in colorectal surgery.
Antithrombotic therapy significantly increases the risk of anastomotic leakage after colorectal surgery, which is critical for patient management.
A 3-stage redo ileal pouch-anal anastomosis significantly reduces pouch failure risk compared to a 2-stage approach.
Surgeons should note that higher surgical volume correlates with better outcomes in total mesorectal excision (TME) for rectal cancer.
Total neoadjuvant therapy (TNT) drastically reduces the risk of distant metastasis in locally advanced rectal cancer compared to traditional methods.
Laparoscopic adhesiolysis for small bowel obstruction (SBO) offers short-term recovery advantages but shows no long-term superiority over open surgery.
Multimodal prehabilitation didn’t significantly reduce complications or hospital stays for elective surgery patients, suggesting a need for focused patient selection.
